M071754 ( DrugBank: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
145	ウエスト症候群	4

145. ウエスト症候群

臨床試験数 : 43 / 薬物数 : 54 - (DrugBank : 15) / 標的遺伝子数 : 27 - 標的パスウェイ数 : 24

diseases per page:

Showing 1 to 4 of 4 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	JPRN-JapicCTI-142559	01/11/2012	02/06/2014	A open-label study of M071754 in patients with infantile spasms	A Long term study of M071754 - A open-label study in patients with infantile spasms -	infantile spasms	Intervention name : M071754 INN of the intervention : vigabatrin Dosage And administration of the inte ...	Alfresa Pharma Corporation	Sanofi KK		0	5	BOTH		Phase 4	NULL
2	JPRN-JapicCTI-142558	01/8/2012		A single-blind study of M071754 in patients with infantile spasms	A Phase III study of M071754 - A single-blind study in patients with infantile spasms -	infantile spasms	Intervention name : M071754 INN of the intervention : vigabatrin Dosage And administration of the inte ...	Alfresa Pharma Corporation	Sanofi KK		0	1	BOTH	12	Phase 3	NULL
3	EUCTR2017-000230-62-Outside-EU/EEA (EUCTR)		24/04/2017	A single-blind study of M071754 in patients with infantile spasms.	A Phase III study of M071754 - A single-blind study in patients with infantile spasms. -	Patients diagnosed with infantile spasms MedDRA version: 19.1;Level: PT;Classification code 10021750 ...	Product Name: VIGABATRIN Product Code: M071754 INN or Proposed INN: VIGABATRIN	Alfresa Pharma Corporation and Sanofi KK	NULL	NA			Female: yes Male: yes	12	Phase 3	Japan
4	EUCTR2017-000611-17-Outside-EU/EEA (EUCTR)		28/08/2017	A open-label study of M071754 in patients with infantile spasms.	A Long term study of M071754 - A open-label study in patients with infantile spasms.	Patients diagnosed with infantile spasms MedDRA version: 20.0;Level: PT;Classification code 10021750 ...	Product Name: VIGABATRIN Product Code: M071754 INN or Proposed INN: VIGABATRIN	Alfresa Pharma Corporation and Sanofi KK	NULL	NA			Female: yes Male: yes	17	Phase 3	Japan

First Previous1Next Last